GEP20196946B - (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine - Google Patents

(s)-pirlindole or its pharmaceutically acceptable salts for use in medicine

Info

Publication number
GEP20196946B
GEP20196946B GEAP201414342A GEAP2014014342A GEP20196946B GE P20196946 B GEP20196946 B GE P20196946B GE AP201414342 A GEAP201414342 A GE AP201414342A GE AP2014014342 A GEAP2014014342 A GE AP2014014342A GE P20196946 B GEP20196946 B GE P20196946B
Authority
GE
Georgia
Prior art keywords
pirlindole
medicine
pharmaceutically acceptable
acceptable salts
pharmaceu
Prior art date
Application number
GEAP201414342A
Inventor
Sociedade Tecnico- Medicinal S.A. Tecnimede
Original Assignee
Tecnimede Sociedade Tecnico Medicinal S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Sociedade Tecnico Medicinal S filed Critical Tecnimede Sociedade Tecnico Medicinal S
Priority to GEAP201414342A priority Critical patent/GEP20196946B/en
Publication of GEP20196946B publication Critical patent/GEP20196946B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

(S)-enantiomer of pirlindole or pharmaceu¬ti¬cally acceptable salt thereof is used in the the¬ra¬peutic treatment and prevention of pain. s
GEAP201414342A 2014-05-09 2014-05-09 (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine GEP20196946B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP201414342A GEP20196946B (en) 2014-05-09 2014-05-09 (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP201414342A GEP20196946B (en) 2014-05-09 2014-05-09 (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine

Publications (1)

Publication Number Publication Date
GEP20196946B true GEP20196946B (en) 2019-02-11

Family

ID=65479048

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201414342A GEP20196946B (en) 2014-05-09 2014-05-09 (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine

Country Status (1)

Country Link
GE (1) GEP20196946B (en)

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
MX2022007221A (en) Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation.
EP3607952A4 (en) Use of carrimycin and pharmaceutically acceptable salt thereof for manufacture of medicament for treatment and/or prevention of tumors
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2019015212A (en) Tinostamustine for use in treating sarcoma.
EP3015111A4 (en) Use of chinese medicine preparation in preparing drug for preventing and/or treating crohn's disease
IL274578A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
IL264407A (en) Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseases
HK1257589A1 (en) Medicine for preventing and treating tissue and organ fibrosis and use of the medicine
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
GB201519557D0 (en) Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
HK1243327A1 (en) Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions
EP3549596A4 (en) Use of microcystins in preparation of drugs for preventing or treating organ and tissue fibrosis diseases
IL272495A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)
ZA202006986B (en) Dantrolene formulations and methods of their use
GEP20196946B (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
GEP20196945B (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
EP3573996A4 (en) Compound with analgesic effect for use in prevention and treatment of pain
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
EA201890122A1 (en) APPLICATION OF 2- (5S-METHIL-2-OXO-4R-PHENILPYRROLIDIN-1-IL) ACETAMIDE IN THE TREATMENT OF SHIPPERS
GB201718838D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
GB201712742D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
TH167851B (en) (S) - Perlindole And its pharmaceutical acceptable salt for Use in medicine